Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial.
Plimack ER, Tangen C, Plets M, Kokate R, Xiu J, Nabhan C, Ross EA, Grundy E, Choi W, Dinney CPN, Lee IC, Fong M, Scott Lucia M, Daneshmand S, Theodorescu D, Goldkorn A, Lerner SP, Flaig TW, McConkey DJ. Plimack ER, et al. Among authors: kokate r. Eur Urol. 2024 Oct;86(4):297-300. doi: 10.1016/j.eururo.2024.06.018. Epub 2024 Jul 14. Eur Urol. 2024. PMID: 39003201
Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events: Review and Outcomes of a Single-institution Initiative.
Zibelman M, Wong V, Reilly J, Zawislak C, Richman D, Keleher C, Herron B, Rafferty C, Tisone T, Rogers B, Kokate R. Zibelman M, et al. Among authors: kokate r. Am J Clin Oncol. 2024 Sep 1;47(9):419-424. doi: 10.1097/COC.0000000000001112. Epub 2024 May 17. Am J Clin Oncol. 2024. PMID: 38757577
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Zibelman M, MacFarlane AW 4th, Costello K, McGowan T, O'Neill J, Kokate R, Borghaei H, Denlinger CS, Dotan E, Geynisman DM, Jain A, Martin L, Obeid E, Devarajan K, Ruth K, Alpaugh RK, Dulaimi EA, Cukierman E, Einarson M, Campbell KS, Plimack ER. Zibelman M, et al. Among authors: kokate r. Nat Commun. 2023 Jul 27;14(1):4513. doi: 10.1038/s41467-023-40028-z. Nat Commun. 2023. PMID: 37500647 Free PMC article. Clinical Trial.
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Jang HJ, Hostetter G, Macfarlane AW, Madaj Z, Ross EA, Hinoue T, Kulchycki JR, Burgos RS, Tafseer M, Alpaugh RK, Schwebel CL, Kokate R, Geynisman DM, Zibelman MR, Ghatalia P, Nichols PW, Chung W, Madzo J, Hahn NM, Quinn DI, Issa JJ, Topper MJ, Baylin SB, Shen H, Campbell KS, Jones PA, Plimack ER. Jang HJ, et al. Among authors: kokate r. Clin Cancer Res. 2023 Jun 1;29(11):2052-2065. doi: 10.1158/1078-0432.CCR-22-3642. Clin Cancer Res. 2023. PMID: 36928921 Free PMC article. Clinical Trial.
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy.
Hemenway G, Lewis B, Ghatalia P, Anari F, Plimack ER, Kokate R, Handorf E, Deng M, Geynisman DM, Zibelman M. Hemenway G, et al. Among authors: kokate r. Eur Urol Oncol. 2023 Aug;6(4):431-436. doi: 10.1016/j.euo.2022.06.005. Epub 2022 Jul 2. Eur Urol Oncol. 2023. PMID: 35792045 Free PMC article.
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial.
Zibelman M, Asghar AM, Parker DC, O'Neill J, Wei S, Greenberg RE, Smaldone MC, Chen DYT, Viterbo R, Uzzo RG, Bloom E, Kokate R, Geynisman DM, Ghatalia P, Deng M, Ross EA, Plimack E, Abbosh PH, Kutikov A. Zibelman M, et al. Among authors: kokate r. J Urol. 2021 Jun;205(6):1605-1611. doi: 10.1097/JU.0000000000001602. Epub 2021 Feb 4. J Urol. 2021. PMID: 33535799 Free PMC article.
15 results